Kaitlin Beemiller, MD
Family Medicine · Gahanna, OHNPI 1316524127
Payments from drug & device makers
Across 118 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$303
- Novo Nordisk$270
- Pfizer$223
- AbbVie$208
- Exact Sciences$123
- Lilly USA, LLC$105
- plus $817 from 19 others
What the payments were for
- Food & beverage$2,049100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $303 |
| Novo Nordisk | 17 | $270 |
| Pfizer | 17 | $223 |
| AbbVie | 17 | $208 |
| Exact Sciences | 4 | $123 |
| Lilly USA, LLC | 6 | $105 |
| Astellas Pharma US Inc | 4 | $102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $81 |
| Boehringer Ingelheim | 4 | $78 |
| Avvisto Therapeutics, LLC | 3 | $69 |
| GSK | 4 | $68 |
| Gilead | 3 | $67 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Medtronic | 1 | $21 |
| Corcept Therapeutics | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Bayer | 1 | $15 |
| Merck | 1 | $15 |
How this compares
$2,049 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 54 | $497 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $386 |
| Duloxetine Hcl | 13 | $354 |
| Gabapentin | 23 | $225 |
| Lisinopril | 31 | $189 |
| Amlodipine Besylate | 27 | $187 |
| Pantoprazole Sodium | 20 | $183 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 15 | $172 |
| Rosuvastatin Calcium | 11 | $150 |
| Escitalopram Oxalate | 11 | $140 |
| Levothyroxine Sodium | 29 | $135 |
| Omeprazole | 11 | $119 |
| Fluticasone Propionate | 13 | $115 |
| Metformin Hcl | 24 | $105 |
| Doxazosin Mesylate | 11 | $83 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Gahanna
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.